MARIA BOYLE: Open Payments
NPI 1063579845 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 61 payments from 13 companies in 2025. Trend: 2023 $268 · 2024 $522 · 2025 $1,348
Food & beverage: $1,338Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $527 |
| Janssen Biotech, Inc. | 9 | $222 |
| Madrigal Pharmaceuticals | 5 | $175 |
| Celltrion USA Inc. | 4 | $125 |
| Aimmune Therapeutics, Inc. | 4 | $111 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Novo Nordisk Inc | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, VEGZELMA, LINZESS, CREON, SKYRIZI, ZENPEP.
Industry payments across FL — which companies pay providers there.
